CAPTRUST Financial Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$154K Buy
10,984
+18
+0.2% +$243 ﹤0.01% 2739
2025
Q4
$123K Sell
10,966
-3,270
-23% -$37.4K ﹤0.01% 2589
2025
Q3
$165K Buy
+14,236
New +$167K ﹤0.01% 2458
2022
Q3
Sell
-2,507
Closed -$69K 2228
2022
Q2
$69K Sell
2,507
-197
-7% -$5.66K ﹤0.01% 2495
2022
Q1
$91K Buy
2,704
+521
+24% +$16.8K ﹤0.01% 2344
2021
Q4
$76K Buy
2,183
+295
+16% +$9.54K ﹤0.01% 2355
2021
Q3
$59K Sell
1,888
-176
-9% -$5.97K ﹤0.01% 2464
2021
Q2
$75K Sell
2,064
-268
-11% -$11.1K ﹤0.01% 2229
2021
Q1
$102K Sell
2,332
-3,350
-59% -$157K ﹤0.01% 1932
2020
Q4
$261K Buy
5,682
+30
+0.5% +$1.25K ﹤0.01% 1087
2020
Q3
$187K Sell
5,652
-382
-6% -$12.2K ﹤0.01% 1061
2020
Q2
$181K Buy
+6,034
New +$175K ﹤0.01% 1074
2019
Q4
Sell
-5,131
Closed -$192K 1063
2019
Q3
$192K Sell
5,131
-51
-1% -$1.95K 0.01% 583
2019
Q2
$226K Buy
5,182
+3,904
+305% +$167K 0.01% 536
2019
Q1
$55K Buy
1,278
+52
+4% +$2.33K ﹤0.01% 879
2018
Q4
$55K Sell
1,226
-279
-19% -$14.6K ﹤0.01% 755
2018
Q3
$103K Buy
1,505
+1,021
+211% +$65.7K ﹤0.01% 585
2018
Q2
$28K Sell
484
-19
-4% -$1K ﹤0.01% 848
2018
Q1
$23K Buy
503
+176
+54% +$8.36K ﹤0.01% 779
2017
Q4
$15K Buy
+327
New +$15K ﹤0.01% 873

Other funds holding AVNS

CAPTRUST Financial Advisors's AVNS Position: Q1 2026 in Review

CAPTRUST Financial Advisors increased its Avanos Medical (AVNS) stake by 0.16% in Q1 2026, buying an estimated $243 and bringing the position to 10,984 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #2739.

CAPTRUST Financial Advisors first reported a position in AVNS in Q4 2017 and has held it in 20 quarters since. The position peaked at $261K in Q4 2020. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • CAPTRUST Financial Advisors held 10,984 shares of Avanos Medical worth $154K as of Q1 2026.
  • CAPTRUST Financial Advisors bought 18 Avanos Medical shares in Q1 2026, an estimated $243.
  • Avanos Medical made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #2739 holding.
  • CAPTRUST Financial Advisors first reported a position in Avanos Medical in Q4 2017 and has held it in 20 quarters since.
  • CAPTRUST Financial Advisors's Avanos Medical position peaked at $261K in Q4 2020.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.